Ginseng composition and application thereof for preventing and treating hemangioma or lymphoma
A composition and technology of hemangioma, applied in the field of medicine, can solve the problems of long treatment cycle, toxic and side effects, etc., and achieve the effect of growth and/or proliferation inhibition
Inactive Publication Date: 2017-08-29
JILIN JIAYI HEALTH IND CO LTD
View PDF1 Cites 1 Cited by
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
However, these methods have long treatment cycles and toxic side effects, which have brought great pain to patients.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View moreImage
Smart Image Click on the blue labels to locate them in the text.
Smart ImageViewing Examples
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0073] Composition 1 was obtained by mixing 9.5g ginsenoside Rb2, 11.6g ginsenoside Rg3, 10.5g ginsenoside Rg5 and 5g starch evenly.
Embodiment 2
[0075] Composition 2 was obtained by mixing 9.5g ginsenoside Rb2, 11.69g ginsenoside Rg3, 10.52g ginsenoside Rg5 and 5g starch evenly.
Embodiment 3
[0077] Composition 3 was obtained by mixing 10.1 g of ginsenoside Rb2, 13.13 g of ginsenoside Rg3, 11.55 g of ginsenoside Rg5 and 5 g of starch.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more PUM
Login to view more Abstract
The Invention belongs to the field of medicines, and relates to a composition. The composition comprises at least one selected from ginsenoside Rb2, ginsenoside Rg3 and ginsenoside Rg5, and/or a plant extract, wherein the plant extract comprises at least one selected from ginsenoside Rb2, ginsenoside Rg3 and ginsenoside Rg5. Moreover, the composition comprises 0.31-0.94 part by weight of ginsenoside Rb2, 1 part by weight of ginsenoside Rg3 and 0.63-1 part by weight of ginsenoside Rg5. On the basis, the invention further relates to medical application of the composition. The composition disclosed by the invention (such as a composition containing a ginseng extract) has obvious effects of inhibiting growth and/or proliferation of hemangioma cells or lymphoma cells, and has an obvious effect of preventing and treating the hemangioma or lymphoma diseases.
Description
technical field [0001] The invention belongs to the field of medicine, and in particular relates to a ginseng composition, and also relates to the application of the composition in preventing and treating hemangioma or lymphoma. Background technique [0002] Panax ginseng belongs to Araliaceae, and its main producing areas include northeast China, North Korea, Japan and eastern Russia. my country's earliest medical masterpiece "Shen Nong's Herbal Classic" has records about the medicinal use of ginseng. Modern medical research has proved that ginseng has various pharmacological activities such as anti-tumor, regulating the central nervous system, regulating the immune system, and anti-hemolysis. [0003] Ginsenosides are the main medicinal ingredients of Araliaceae Panax genus plants (including ginseng, American ginseng, Panax notoginseng, etc.), which have various effects such as enhancing immunity, anti-fatigue, anti-tumor, anti-hypoxia, anti-aging, and hypoglycemic. Gins...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more Application Information
Patent Timeline
Login to view more Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/258A61P35/00A61K31/704
CPCA61K31/704A61K36/258A61K2300/00
Inventor 裴文国王璐韩杨赵洪梅汪研李晓华严哲董青松
Owner JILIN JIAYI HEALTH IND CO LTD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Try Eureka
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap